Table 1.
Challenge | Model | Result | Reference |
---|---|---|---|
TcdA/B | ASC-/- Mice Anakinra (IL-1Ra) Mice |
Decrease in disease severity | Ng, 2010 |
TcdA | MIP-2 Neutralized Rat | Decrease in disease severity | Castagliuolo, 1998 |
TcdA | CCR1-/- Mice MIP1α -/- Mice |
Decrease in disease severity | Morteau, 2002 |
TcdA | Anti-CD18 mAB (neutrophil depletion) Rabbit | Decrease in disease severity | Kelly, 1994 |
TcdA | IFN-γ -/- Mice IFN-γ Neutralized Mice |
Decrease in disease severity | Ishida, 2004 |
TcdA | Mast Cell Deficient Mice | Decrease in disease severity | Wershil, 1998 |
TcdA | Ob/ob (Leptin Deficient) Mice | Decrease in disease severity | Mykoniatis, 2003 |
VPI 10463 | Nod1-/- Mice | Decreased survival | Hasegawa, 2011 |
VPI 10463 | ASC-/- Mice | Decreased survival | Hasegawa, 2012 |
VPI 10463 | MyD88-/- Mice Neutrophil depleted Mice |
Decreased survival | Jarchum, 2012 |
R13537 | TLR4-/- Mice | Decreased survival | Ryan, 2011 |
VPI 10463 | IL-23p19-/- Mice | Increased survival | Buonomo, 2013 |